Six Months DHEA Treatment in Female Adrenal Failure

• Status: Completed
• Trial end date: 2003-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

DHEA is an adrenal deriven androgen precourser. The impact of DHEA substitution therapy in adrenal failure is unknown as well as the physiologically effects of DHEA is unknown. Effects of physiologically DHEA substitution is investigated in the model of female adrenal failure.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Aarhus
• Treatments: Dehydroepiandrosterone

Criteria

Inclusion Criteria:

• Female,

• Adrenal insuficiency,

• Stable and safe anticonception,

• Stable hydrocortison substituation treatment.

Exclusion Criteria:

• Neoplastic and thromboembolic disease,

• Diabetes mellitus.